P. A. Cortesi, D. Paolicelli, M. Capobianco, P. Cozzolino, and L. G. Mantovani, “The Value and Sustainability of Ocrelizumab in Relapsing Multiple Sclerosis: A Cost-Effectiveness and Budget Impact Analysis”, FE, vol. 20, no. 1, Jul. 2019.